Skip to main content

NORDEA INVESTMENT MANAGEMENT AB

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1218210 STOCKHOLM, V7

Position in KNSA

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$6,852,689
+$1,718,215 QoQ
Shares Held
107,157
+0.5% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 264 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NORDEA INVESTMENT MANAGEMENT AB holds $598,092,248 across 11 Drug Manufacturers - Specialty & Generic names. KNSA ranks #5 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 KNSA
Kiniksa Pharmaceuticals International, plc
This page
107,157 $6,852,689

All Filings in KNSA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,852,689 107,157
2026-03-31 $5,134,474 106,635
2025-12-31 $4,565,632 110,682
2025-09-30 $5,089,603 131,074
2025-06-30 $3,601,527 130,160
2025-03-31 $2,843,989 128,050
2024-12-31 $3,854,784 194,883
2024-09-30 $4,663,782 186,626